Skip to search.
 TSX Up 0.30% TSX Ventures Down 0.15%

Opexa Therapeutics, Inc. (OPXA)

-NasdaqCM
0.44 Down 0.01(1.98%) Jul 2, 4:00PM EDT
Add to Portfolio
Prev Close:0.45
Open:0.45
Bid:0.44 x 1000
Ask:0.53 x 10000
1y Target Est:5.00
Beta:2.05
Earnings Date:Aug 12 - Aug 17 (Est.)
Day's Range:0.44 - 0.47
52wk Range:0.33 - 1.69
Volume:497,414
Avg Vol (3m):1,619,880
Market Cap:23.53M
P/E (ttm):N/A
EPS (ttm):-0.53
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

Comparison

Symbol% ChgMkt Cap
OPXADown 1.98%23.53M
SNYDown 0.58%129.36B
TEVAUp 1.00%52.20B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):18.46
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.36
Quarterly EPS Est (Jun-15) :-0.08
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Opexa Therapeutics, Inc., a biopharmaceutical company, develops personalized immunotherapy to treat multiple sclerosis (MS) and other autoimmune diseases, such as neuromyelitis optica (NMO) based on its proprietary T-cell technology. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback